Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 261

1.

Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

Racine AM, Koscik RL, Berman SE, Nicholas CR, Clark LR, Okonkwo OC, Rowley HA, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Gleason CE, Carlsson CM, Johnson SC.

Brain. 2016 Jun 20. pii: aww142. [Epub ahead of print]

PMID:
27324877
2.

Multi-Language Online Handwriting Recognition.

Keysers D, Deselaers T, Rowley HA, Wang LL, Carbune V.

IEEE Trans Pattern Anal Mach Intell. 2016 May 25. [Epub ahead of print]

PMID:
27244718
3.

Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.

Racine AM, Koscik RL, Nicholas CR, Clark LR, Okonkwo OC, Oh JM, Hillmer AT, Murali D, Barnhart TE, Betthauser TJ, Gallagher CL, Rowley HA, Dowling NM, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Carlsson CM, Christian BT, Johnson SC.

Alzheimers Dement (Amst). 2016;2:27-38.

4.

Fornix Microstructure and Memory Performance Is Associated with Altered Neural Connectivity during Episodic Recognition.

Ly M, Adluru N, Destiche DJ, Lu SY, Oh JM, Hoscheidt SM, Alexander AL, Okonkwo OC, Rowley HA, Sager MA, Johnson SC, Bendlin BB.

J Int Neuropsychol Soc. 2016 Feb;22(2):191-204. doi: 10.1017/S1355617715001216.

PMID:
26888616
5.

Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.

Melah KE, Lu SY, Hoscheidt SM, Alexander AL, Adluru N, Destiche DJ, Carlsson CM, Zetterberg H, Blennow K, Okonkwo OC, Gleason CE, Dowling NM, Bratzke LC, Rowley HA, Sager MA, Asthana S, Johnson SC, Bendlin BB.

J Alzheimers Dis. 2015;50(3):873-86. doi: 10.3233/JAD-150897.

6.

Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.

Clark LR, Racine AM, Koscik RL, Okonkwo OC, Engelman CD, Carlsson CM, Asthana S, Bendlin BB, Chappell R, Nicholas CR, Rowley HA, Oh JM, Hermann BP, Sager MA, Christian BT, Johnson SC.

Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03033-2. doi: 10.1016/j.jalz.2015.12.009. [Epub ahead of print]

PMID:
26806386
7.

Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease.

Berman SE, Rivera-Rivera LA, Clark LR, Racine AM, Keevil JG, Bratzke LC, Carlsson CM, Bendlin BB, Rowley HA, Blennow K, Zetterberg H, Asthana S, Turski P, Johnson SC, Wieben O.

Alzheimers Dement (Amst). 2015 Dec 1;1(4):420-428.

8.

4D flow MRI for intracranial hemodynamics assessment in Alzheimer's disease.

Rivera-Rivera LA, Turski P, Johnson KM, Hoffman C, Berman SE, Kilgas P, Rowley HA, Carlsson CM, Johnson SC, Wieben O.

J Cereb Blood Flow Metab. 2015 Nov 25. pii: 0271678X15617171. [Epub ahead of print]

PMID:
26661239
9.

CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.

Caine C, Deshmukh S, Gondi V, Mehta M, Tomé W, Corn BW, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, Konski AA, Bauman GS, Raben A, Shi W, Wendland M, Kachnic L.

J Neurooncol. 2016 Jan;126(2):327-36. doi: 10.1007/s11060-015-1971-2. Epub 2015 Oct 28.

PMID:
26511494
10.

The relationship between carotid artery plaque stability and white matter ischemic injury.

Berman SE, Wang X, Mitchell CC, Kundu B, Jackson DC, Wilbrand SM, Varghese T, Hermann BP, Rowley HA, Johnson SC, Dempsey RJ.

Neuroimage Clin. 2015 Aug 22;9:216-22. doi: 10.1016/j.nicl.2015.08.011. eCollection 2015.

11.
12.

The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cue.

Hutson PH, Rowley HL, Gosden J, Kulkarni RS, Slater N, Love PL, Wang Y, Heal D.

Neuropharmacology. 2016 Feb;101:24-35. doi: 10.1016/j.neuropharm.2015.09.014. Epub 2015 Sep 16.

PMID:
26384654
13.

Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.

Doherty BM, Schultz SA, Oh JM, Koscik RL, Dowling NM, Barnhart TE, Murali D, Gallagher CL, Carlsson CM, Bendlin BB, LaRue A, Hermann BP, Rowley HA, Asthana S, Sager MA, Christian BT, Johnson SC, Okonkwo OC.

Alzheimers Dement (Amst). 2015 Jun 1;1(2):160-169.

14.

Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease.

Boots EA, Schultz SA, Almeida RP, Oh JM, Koscik RL, Dowling MN, Gallagher CL, Carlsson CM, Rowley HA, Bendlin BB, Asthana S, Sager MA, Hermann BP, Johnson SC, Okonkwo OC.

Arch Clin Neuropsychol. 2015 Nov;30(7):634-42. doi: 10.1093/arclin/acv041. Epub 2015 Jul 8.

PMID:
26156334
15.

A field demonstration of the costs and benefits of group living to edible and defended prey.

Curley EA, Rowley HE, Speed MP.

Biol Lett. 2015 Jun;11(6):20150152. doi: 10.1098/rsbl.2015.0152.

16.

Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD.

Schultz SA, Oh JM, Koscik RL, Dowling NM, Gallagher CL, Carlsson CM, Bendlin BB, LaRue A, Hermann BP, Rowley HA, Asthana S, Sager MA, Johnson SC, Okonkwo OC.

Alzheimers Dement (Amst). 2015 Mar 1;1(1):33-40.

17.

Determination of Injury Risks and Safety Measures Taken by Mothers of Children With an Intellectual Disability and Autism Spectrum Disorder.

Yıldırım Sarı H, Girli A, Ozturk Ozgonenel S, Rowley H.

Int J Nurs Knowl. 2016 Feb;27(2):95-103. doi: 10.1111/2047-3095.12079. Epub 2015 Mar 10.

PMID:
25759189
18.

Real-time pretreatment review limits unacceptable deviations on a cooperative group radiation therapy technique trial: quality assurance results of RTOG 0933.

Gondi V, Cui Y, Mehta MP, Manfredi D, Xiao Y, Galvin JM, Rowley H, Tome WA.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):564-70. doi: 10.1016/j.ijrobp.2014.10.054. Epub 2015 Jan 10.

19.

First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.

Hillmer AT, Wooten DW, Bajwa AK, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Rowley HA, Stone CK, Johnson SC, Mukherjee J, Christian BT.

J Nucl Med. 2014 Dec;55(12):1973-9. doi: 10.2967/jnumed.114.145151. Epub 2014 Nov 13.

20.

Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer's disease.

Schultz SA, Larson J, Oh J, Koscik R, Dowling MN, Gallagher CL, Carlsson CM, Rowley HA, Bendlin BB, Asthana S, Hermann BP, Johnson SC, Sager M, LaRue A, Okonkwo OC.

Brain Imaging Behav. 2015 Dec;9(4):729-36. doi: 10.1007/s11682-014-9329-5.

PMID:
25358750
Items per page

Supplemental Content

Loading ...
Write to the Help Desk